Author Page for Ingrid Boere

Phenotype-Guided Targeted Therapy Based on Functional Signal Transduction Pathway Activity in Recurrent Ovarian Cancer Patients: The Stapover Study Protocol

Number of pages: 24 Posted: 18 May 2023

Phyllis van der Ploeg, Cynthia Hendrikse, Anna Thijs, Hans M. Westgeest, Huberdina Smedts, Caroline Vos, Mathilde Jalving, C.A.R. Lok, Ingrid Boere, Maaike van Ham, Nelleke Ottevanger, Anneke M. Westermann, Constantijne Mom, Roy Lalisang, Sandrina Lambrechts, Ruud Bekkers and Jurgen M.J. Piek

Maastricht University, Catharina Hospital, Catharina Hospital, Amphia Hospital - Department of Internal Mediine, Amphia Hospital, Elisabeth-Tweesteden Hospital - Department of Obstetrics and Gynecology, University of Groningen - Department of Medical Oncology, Medical University of Gdańsk - Department of Oncology and Radiotherapy, Erasmus University Rotterdam (EUR), Radboud University Nijmegen - Radboud University Medical Center, Radboud University, University of Amsterdam - University Medical Center, University of Amsterdam - University Medical Center, Maastricht University, Maastricht University, Catharina Hospital and Catharina Hospital

Downloads 53 (1,031,043)

Abstract:

2.

Changes in Bone Marrow Fat Fraction and Immune Cell Counts in Women with Cervical Cancer Treated with Primary Chemoradiotherapy

Number of pages: 23 Posted: 04 Apr 2025

Anouk Corbeau, Eleftheria Asteinidou, Sander Cyril Kuipers, Piotr A. Wielopolski, Wendy Visser, Jan-Willem M. Mens, Henrike Westerveld, Mila Donker, Laura A. Velema, Judith R. Kroep, Ingrid Boere, Marij J.P. Welters, Sjoerd H. van der Burg, Mischa Hoogeman, H. Putter, Jérémy Godart, Uulke A. van der Heide, Carien L. Creutzberg, Remi A. Nout and Stephanie M. de Boer

Leiden University - Leiden University Medical Center (LUMC), affiliation not provided to SSRN, Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, University of Amsterdam - University Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR), affiliation not provided to SSRN, Leiden University - Department of Medical Oncology,, Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, Leiden University - Leiden University Medical Center (LUMC), Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, Netherlands Cancer Institute, Leiden University - Department of Radiation Oncology, Erasmus University Medical Center Rotterdam - Department of Radiation Oncology and Leiden University - Department of Radiation Oncology

Downloads 28 (1,345,526)

Abstract:

3.

Genome-Wide Cell-Free DNA Methylation Profiling in Advanced Stage Ovarian Cancer. Are We Looking at the Tumor or the Patient's Immune Response to the Tumor?

Number of pages: 32 Posted: 17 Jan 2025

Caroline B. van den Berg, Gatske M. Nieuwenhuyzen-de Boer, Ingrid Boere, Ruben G. Boers, Joachim B. Boers, Wilfred F.J. van IJcken, Maurice P.H.M. Jansen, Tugce S. Kirmizitas, Joost H. Gribnau, Heleen J. van Beekhuizen and Sneak Peek Administrator

Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR), Erasmus University Rotterdam (EUR) and Independent

Downloads 25 (1,385,945)

Ingrid Boere

Erasmus University Rotterdam (EUR)

3

106

0

Scholarly Papers (3)

Phenotype-Guided Targeted Therapy Based on Functional Signal Transduction Pathway Activity in Recurrent Ovarian Cancer Patients: The Stapover Study Protocol

Abstract:

Changes in Bone Marrow Fat Fraction and Immune Cell Counts in Women with Cervical Cancer Treated with Primary Chemoradiotherapy

Abstract:

Genome-Wide Cell-Free DNA Methylation Profiling in Advanced Stage Ovarian Cancer. Are We Looking at the Tumor or the Patient's Immune Response to the Tumor?

Abstract: